Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 646171, 13 pages
http://dx.doi.org/10.1155/2015/646171
Research Article

Potential Therapeutic Role of L-Carnitine in Skeletal Muscle Oxidative Stress and Atrophy Conditions

1Department of Biomedical Sciences for Health, University of Milan, Milan, Italy
2Metabolism Research Center, San Donato Hospital and Scientific Institute, Milan, Italy
3Diabetes Research Institute, Metabolism, Nutrigenomics and Cellular Differentiation Unit, San Raffaele Scientific Institute, 60 Olgettina street, 20132 Milan, Italy

Received 26 November 2014; Accepted 23 January 2015

Academic Editor: Ryuichi Morishita

Copyright © 2015 Anna Montesano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Nabavi, M. Daglia, A. H. Moghaddam, S. F. Nabavi, and V. Curti, “Tea consumption and risk of ischemic stroke: a brief review of the literature,” Current Pharmaceutical Biotechnology, vol. 15, no. 4, pp. 298–303, 2014. View at Publisher · View at Google Scholar
  2. M. Daglia, A. di Lorenzo, S. F. Nabavi, Z. S. Talas, and S. M. Nabavi, “Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!,” Current Pharmaceutical Biotechnology, vol. 15, no. 4, pp. 362–372, 2014. View at Publisher · View at Google Scholar
  3. A. García-Lafuente, C. Moro, N. Manchón et al., “In vitro anti-inflammatory activity of phenolic rich extracts from white and red common beans,” Food Chemistry, vol. 161, pp. 216–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Flachs, M. Rossmeisl, and J. Kopecky, “The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity,” Physiological Research, vol. 63, pp. S93–S118, 2014. View at Google Scholar · View at Scopus
  5. A. Aartsma-Rus, G. J. van Ommen, and J. Kaplan, “Innovating therapies for muscle diseases,” in Handbook of Clinical Neurology, vol. 113, pp. 1497–1501, North-Holland Publisher, 2013. View at Google Scholar
  6. F. Landi, E. Marzetti, A. M. Martone, R. Bernabei, and G. Onder, “Exercise as a remedy for sarcopenia,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 1, pp. 25–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. D'Antona, S. M. Nabavi, P. Micheletti et al., “Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle,” BioMed Research International, vol. 2014, Article ID 613890, 16 pages, 2014. View at Publisher · View at Google Scholar
  8. M. Wyss and R. Kaddurah-Daouk, “Creatine and creatinine metabolism,” Physiological Reviews, vol. 80, no. 3, pp. 1107–1213, 2000. View at Google Scholar · View at Scopus
  9. A. Huang and K. Owen, “Role of supplementary L-carnitine in exercise and exercise recovery,” Medicine and Sport Science, vol. 59, pp. 135–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Dutta, K. Ray, V. K. Singh, P. Vats, S. N. Singh, and S. B. Singh, “L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats,” Experimental Physiology, vol. 93, no. 10, pp. 1139–1146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Ringseis, J. Keller, and K. Eder, “Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies,” European Journal of Nutrition, vol. 52, no. 5, pp. 1421–1442, 2013. View at Google Scholar
  12. J. Yu, J. Ye, X. Liu, Y. Han, and C. Wang, “Protective effect of L-carnitine against H2O2-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells,” Neurological Research, vol. 33, no. 7, pp. 708–716, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Johnson, M. M. Robinson, and S. K. Nair, “Skeletal muscle aging and the mitochondrion,” Trends in Endocrinology and Metabolism, vol. 24, no. 5, pp. 247–256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. G. Tidball, “Mechanisms of muscle injury, repair, and regeneration,” Comprehensive Physiology, vol. 1, no. 4, pp. 2029–2062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Montesano, L. Luzi, P. Senesi, and I. Terruzzi, “Modulation of cell cycle progression by 5-azacytidine is associated with early myogenesis induction in murine myoblasts,” International Journal of Biological Sciences, vol. 9, no. 4, pp. 391–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Senesi, L. Luzi, A. Montesano, N. Mazzocchi, and I. Terruzzi, “Betaine supplement enhances skeletal muscle differentiation in murine myoblasts via IGF-1 signaling activation,” Journal of Translational Medicine, vol. 11, article 174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Montesano, L. Luzi, P. Senesi, N. Mazzocchi, and I. Terruzzi, “Resveratrol promotes myogenesis and hypertrophy in murine myoblasts,” Journal of Translational Medicine, vol. 11, no. 1, article 310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Senesi, L. Luzi, A. Montesano, and I. Terruzzi, “DNA demethylation enhances myoblasts hypertrophy during the late phase of myogenesis activating the IGF-I pathway,” Endocrine, vol. 47, no. 1, pp. 244–254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Terruzzi, P. Senesi, C. Magni et al., “Insulin-mimetic action of conglutin-γ, a lupin seed protein, in mouse myoblasts,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 3, pp. 197–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Perry and M. A. Rudnick, “Molecular mechanisms regulating myogenic determination and differentiation,” Frontiers in Bioscience, vol. 5, pp. D750–D767, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-H. Arnold and B. Winter, “Muscle differentiation: more complexity to the network of myogenic regulators,” Current Opinion in Genetics and Development, vol. 8, no. 5, pp. 539–544, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. R. Knight and R. Kothary, “The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis,” Skeletal Muscle, vol. 1, no. 1, article 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Glass, “Signalling pathways that mediate skeletal muscle hypertrophy and atrophy,” Nature Cell Biology, vol. 5, no. 2, pp. 87–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Bodine, T. N. Stitt, M. Gonzalez et al., “Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo,” Nature Cell Biology, vol. 3, no. 11, pp. 1014–1019, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Rommel, S. C. Bodine, B. A. Clarke et al., “Mediation of IGF-1-induced skeletal myotube hypertrophy by Pl(3)K/Alt/mTOR and Pl(3)K/Akt/GSK3 pathways,” Nature Cell Biology, vol. 3, no. 11, pp. 1009–1013, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Li and S. E. Johnson, “ERK2 is required for efficient terminal differentiation of skeletal myoblasts,” Biochemical and Biophysical Research Communications, vol. 345, no. 4, pp. 1425–1433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Flynn and S. Melovn, “SOD2 in mitochondrial dysfunction and neurodegeneration,” Free Radical Biology and Medicine, vol. 62, pp. 4–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. L. Joiner, O. M. Koval, J. Li et al., “CaMKII determines mitochondrial stress responses in heart,” Nature, vol. 491, no. 7423, pp. 269–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Pekala, B. Patkowska-Sokoła, R. Bodkowski et al., “L-carnitine—metabolic functions and meaning in humans life,” Current Drug Metabolism, vol. 12, no. 7, pp. 667–678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Kita, S. Kato, M. A. Yaman, J. Okumura, and H. Yokota, “Dietary L-carnitine increases plasma insulin-like growth factor-I concentration in chicks fed a diet with adequate dietary protein level,” British Poultry Science, vol. 43, no. 1, pp. 117–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Doberenz, C. Birkenfeld, H. Kluge, and K. Eder, “Effects of L-carnitine supplementation in pregnant sows on plasma concentrations of insulin-like growth factors, various hormones and metabolites and chorion characteristics,” Journal of Animal Physiology and Animal Nutrition, vol. 90, no. 11-12, pp. 487–499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. K. R. Brown, R. D. Goodband, M. D. Tokach et al., “Effects of feeding L-carnitine to gilts through day 70 of gestation on litter traits and the expression of insulin-like growth factor system components and L-carnitine concentration in foetal tissues,” Journal of Animal Physiology and Animal Nutrition, vol. 92, no. 6, pp. 660–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Keller, R. Ringseis, and K. Eder, “Supplemental carnitine affects the microRNA expression profile in skeletal muscle of obese Zucker rats,” BMC Genomics, vol. 15, article 512, 2014. View at Google Scholar
  34. J. Keller, A. Couturier, M. Haferkamp, E. Most, and K. Eder, “Supplementation of carnitine leads to an activation of the IGF-1/PI3K/Akt signalling pathway and down regulates the E3 ligase MuRF1 in skeletal muscle of rats,” Nutrition and Metabolism, vol. 10, no. 1, article 28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. V. C. Foletta, L. J. White, A. E. Larsen, B. Léger, and A. P. Russell, “The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy,” Pflugers Archiv, vol. 461, no. 3, pp. 325–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. K. Powers, A. N. Kavazis, and J. M. McClung, “Oxidative stress and disuse muscle atrophy,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2389–2397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. J. P. Gumucio and C. L. Mendias, “Atrogin-1, MuRF-1, and sarcopenia,” Endocrine, vol. 43, no. 1, pp. 12–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Keller, R. Ringseis, A. Koc, I. Lukas, H. Kluge, and K. Eder, “Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets,” Animal, vol. 6, no. 1, pp. 70–78, 2012. View at Google Scholar
  39. J. Keller, R. Ringseis, S. Priebe, R. Guthke, H. Kluge, and K. Eder, “Dietary L-carnitine alters gene expression in skeletal muscle of piglets,” Molecular Nutrition and Food Research, vol. 55, no. 3, pp. 419–429, 2011. View at Google Scholar
  40. S. Busquets, R. Serpe, M. Toledo et al., “L-carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer,” Clinical Nutrition, vol. 31, no. 6, pp. 889–895, 2012. View at Google Scholar
  41. R. A. Fielding, B. Vellas, W. J. Evans et al., “Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia,” Journal of the American Medical Directors Association, vol. 12, no. 4, pp. 249–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. C. Forbes, J. P. Little, and D. G. Candow, “Exercise and nutritional interventions for improving aging muscle health,” Endocrine, vol. 42, no. 1, pp. 29–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Benedini, G. Perseghin, I. Terruzzi et al., “Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy,” Hormone and Metabolic Research, vol. 41, no. 11, pp. 840–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Couturier, R. Ringseis, F. C. Mooren, K. Krüger, E. Most, and K. Eder, “Correction: carnitine supplementation to obese Zucker rats prevents obesity-induced type I to type II muscle fiber transition and favors an oxidative phenotype of skeletal muscle,” Nutrition and Metabolism, vol. 11, no. 1, article 16, 2014. View at Google Scholar
  45. B. Chang, M. Nishikawa, E. Sato, K. Utsumi, and M. Inoue, “L-carnitine inhibits cisplatin-induced injury of the kidney and small intestine,” Archives of Biochemistry and Biophysics, vol. 405, no. 1, pp. 55–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Gülçin, “Antioxidant and antiradical activities of L-carnitine,” Life Sciences, vol. 78, no. 8, pp. 803–811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. E. J. Anderson, M. E. Lustig, K. E. Boyle et al., “Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 573–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. I. Rachek, “Free fatty acids and skeletal muscle insulin resistance,” Progress in Molecular Biology and Translational Science, vol. 121, pp. 267–292, 2014. View at Publisher · View at Google Scholar · View at Scopus